CN107400182A - 舒更葡糖钠晶型a及其制备方法和用途 - Google Patents
舒更葡糖钠晶型a及其制备方法和用途 Download PDFInfo
- Publication number
- CN107400182A CN107400182A CN201710498569.9A CN201710498569A CN107400182A CN 107400182 A CN107400182 A CN 107400182A CN 201710498569 A CN201710498569 A CN 201710498569A CN 107400182 A CN107400182 A CN 107400182A
- Authority
- CN
- China
- Prior art keywords
- glucose sodium
- easypro
- crystal
- preparation
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组成 | 用量(每瓶) |
舒更葡糖钠晶型A | 100.0mg |
甘露醇 | 500.0mg |
乙二胺四乙酸二钠 | 0.2mg |
组成 | 用量(每瓶) |
舒更葡糖钠晶型A | 500.0mg |
注射用水 | 5.0ml |
盐酸或氢氧化钠 | 适量至pH7.0~7.5 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710498569.9A CN107400182A (zh) | 2017-06-26 | 2017-06-26 | 舒更葡糖钠晶型a及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710498569.9A CN107400182A (zh) | 2017-06-26 | 2017-06-26 | 舒更葡糖钠晶型a及其制备方法和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107400182A true CN107400182A (zh) | 2017-11-28 |
Family
ID=60405076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710498569.9A Withdrawn CN107400182A (zh) | 2017-06-26 | 2017-06-26 | 舒更葡糖钠晶型a及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107400182A (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110615860A (zh) * | 2018-06-20 | 2019-12-27 | 江苏恒瑞医药股份有限公司 | 一种舒更葡糖钠的纯化方法 |
WO2020028448A1 (en) * | 2018-08-02 | 2020-02-06 | Pliva Hrvatska D.O.O. | Solid state forms of sugammadex sodium |
CN110818816A (zh) * | 2018-08-10 | 2020-02-21 | 乳源东阳光药业有限公司 | 一种舒更葡糖钠的精制结晶方法 |
WO2021008486A1 (zh) * | 2019-07-13 | 2021-01-21 | 刘力 | 肌松拮抗的新化合物 |
CN112538124A (zh) * | 2019-09-20 | 2021-03-23 | 鲁南制药集团股份有限公司 | 一种舒更葡糖钠晶型 |
CN112752770A (zh) * | 2018-09-27 | 2021-05-04 | 韦尔滕施泰因生物制药公司 | 舒更葡糖的新型晶体形式 |
EP3932391A1 (en) | 2020-07-03 | 2022-01-05 | Galenicum Health S.L.U. | Method to prepare pharmaceutical compositions |
WO2022055918A1 (en) * | 2020-09-09 | 2022-03-17 | Merck Sharp & Dohme Corp. | Novel crystalline forms of sugammadex |
CN114276475A (zh) * | 2020-09-28 | 2022-04-05 | 台湾神隆股份有限公司 | 舒更葡糖钠的晶型s1及其制备方法 |
CN116606388A (zh) * | 2023-06-09 | 2023-08-18 | 北京阳光诺和药物研究股份有限公司 | 一种舒更葡糖钠的α晶型及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017084401A1 (zh) * | 2016-06-29 | 2017-05-26 | 北京睿创康泰医药研究院有限公司 | 舒更葡糖钠的制备及纯化方法 |
CN106749771A (zh) * | 2015-11-23 | 2017-05-31 | 成都渊源生物科技有限公司 | 一种高纯度的舒更葡糖钠制备方法 |
-
2017
- 2017-06-26 CN CN201710498569.9A patent/CN107400182A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106749771A (zh) * | 2015-11-23 | 2017-05-31 | 成都渊源生物科技有限公司 | 一种高纯度的舒更葡糖钠制备方法 |
WO2017084401A1 (zh) * | 2016-06-29 | 2017-05-26 | 北京睿创康泰医药研究院有限公司 | 舒更葡糖钠的制备及纯化方法 |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110615860A (zh) * | 2018-06-20 | 2019-12-27 | 江苏恒瑞医药股份有限公司 | 一种舒更葡糖钠的纯化方法 |
WO2020028448A1 (en) * | 2018-08-02 | 2020-02-06 | Pliva Hrvatska D.O.O. | Solid state forms of sugammadex sodium |
CN110818816A (zh) * | 2018-08-10 | 2020-02-21 | 乳源东阳光药业有限公司 | 一种舒更葡糖钠的精制结晶方法 |
CN112752770A (zh) * | 2018-09-27 | 2021-05-04 | 韦尔滕施泰因生物制药公司 | 舒更葡糖的新型晶体形式 |
JP2022501489A (ja) * | 2018-09-27 | 2022-01-06 | ヴェルテンシュタイン・バイオファーマ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | スガマデクスの新規結晶型 |
WO2021008486A1 (zh) * | 2019-07-13 | 2021-01-21 | 刘力 | 肌松拮抗的新化合物 |
CN112279937A (zh) * | 2019-07-13 | 2021-01-29 | 刘力 | 肌松拮抗的新化合物 |
CN112538124A (zh) * | 2019-09-20 | 2021-03-23 | 鲁南制药集团股份有限公司 | 一种舒更葡糖钠晶型 |
EP3932391A1 (en) | 2020-07-03 | 2022-01-05 | Galenicum Health S.L.U. | Method to prepare pharmaceutical compositions |
WO2022055918A1 (en) * | 2020-09-09 | 2022-03-17 | Merck Sharp & Dohme Corp. | Novel crystalline forms of sugammadex |
CN114276475A (zh) * | 2020-09-28 | 2022-04-05 | 台湾神隆股份有限公司 | 舒更葡糖钠的晶型s1及其制备方法 |
CN116606388A (zh) * | 2023-06-09 | 2023-08-18 | 北京阳光诺和药物研究股份有限公司 | 一种舒更葡糖钠的α晶型及其制备方法 |
CN116606388B (zh) * | 2023-06-09 | 2023-11-28 | 北京阳光诺和药物研究股份有限公司 | 一种舒更葡糖钠的α晶型及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107400182A (zh) | 舒更葡糖钠晶型a及其制备方法和用途 | |
US11739069B2 (en) | Modulators of resistant androgen receptor | |
CN102351857B (zh) | 盐酸托烷司琼化合物 | |
CN107759594A (zh) | 选择性cdk4/6抑制剂的固态形式 | |
EP2870163B1 (en) | Pharmaceutical compositions comprising rifaximin and amino acids, preparation method and use thereof | |
TW200838512A (en) | Crystalline forms of a thiazolidinedione compound and manufacturing methods thereof | |
TW201247680A (en) | Amorphous N-benzoyl-staurosporine, processes for the preparation, and use thereof | |
EP3560919A1 (en) | Salt of substituted piperidine compound | |
EP3365321B1 (en) | Solabegron zwitterion and uses thereof | |
CN103864760A (zh) | 一种盐酸法舒地尔化合物 | |
CN103073542A (zh) | 一种枸橼酸托烷司琼晶型ⅱ的制备和应用 | |
WO2007082471A1 (en) | Anti-infective compound, preparation method thereof and use thereof | |
TW202200594A (zh) | 一種glp-1受體激動劑的晶型a及其製備方法 | |
CN110054606B (zh) | 一种二氢杨梅素-盐酸黄连素药物共晶及制备方法 | |
TW200800306A (en) | Sustained-release formulation and uses thereof | |
CN108640910A (zh) | 阿瑞吡坦l-脯氨酸溶剂化物-组合物和共晶体 | |
CN109843300A (zh) | 3-羟基-4,5-双苄氧基-6-苄氧基甲基-2-苯基-2-氧代-2λ5-[1,2]氧杂膦环己烷的结晶多晶型形式 | |
CN108553649B (zh) | 一种新颖的管道结构的索拉非尼-γ-环糊精包合物及制备方法及应用 | |
CN103819487B (zh) | 一种利福平晶体及其制备方法 | |
CN103073543A (zh) | 一种枸橼酸托烷司琼晶型ⅰ的制备和应用 | |
CN104211693B (zh) | 一种利伐沙班晶型及其制备方法与用途 | |
CN102603738B (zh) | 一种稳定的盐酸莫西沙星化合物 | |
KR20120070354A (ko) | 올메사탄 메독소밀 및 그 정제의 제조방법 | |
WO2023280090A1 (zh) | 一种药用组合物及其制备方法和用途 | |
CN107151261A (zh) | 一种地红霉素化合物的晶型及其结晶制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Di Fumin Inventor after: Hu Yuqian Inventor after: Li Huiwu Inventor after: Zhu Gaojun Inventor after: Liu Yong Inventor after: Hu Quangen Inventor before: Zhao Wangming Inventor before: Di Fumin Inventor before: Li Huiwu Inventor before: Zhang Jing Inventor before: Shi Wenge |
|
CB03 | Change of inventor or designer information | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20171128 |
|
WW01 | Invention patent application withdrawn after publication |